Overview
Dr. Robert A. Harrington is a cardiologist and serves as the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine and Provost for Medical Affairs of Cornell University. His research areas of focus include evaluating antithrombotic therapies to treat acute ischemic heart disease and to minimize the acute complications of percutaneous coronary procedures and trying to better understand and improve upon the methodology of clinical research, including the use of technologies to facilitate the conduct of clinical trials.
Highlights
- 1
- 2
- 3Journal of the American College of Cardiology · 2024
Publications
Funding
Active
1 grant- Sub-PISPO 260383Janssen Milvexian Program.Janssen Research & Development, LLC · 2023–2026 · via Stanford University
Completed grants (3)
- PIRC2HL101512-01ACC/Duke Partnership for a National Cardiovascular Research Infrastructure (NCRI)NHLBI · 2009–2011 · via NIH RePORTER
- PIN01HC045218-0-0-0Re-Engineering the Clinical Research EnterpriseNIH · 2004–2007 · via NIH RePORTER
Honors & distinctions
- Member · National Academy of Medicine
- Member · Association of American Physicians
News mentions
- State of Weill Cornell Medicine: A Bright FutureDecember 19, 2025
Weill Cornell Medicine is poised to thrive in the coming years, with a planned expansion of its clinical enterprise serving as an engine for overall institutional growth, Dean Robert Harrington conveyed Dec. 16 during his biannual State of Weill Cornell Medicine address.
- Improving Lives Through Academic Innovation, Commercialization and EntrepreneurshipDecember 5, 2025
Weill Cornell Medicine’s Ninth Annual Dean’s Symposium on Innovation and Entrepreneurship celebrated and fostered the entrepreneurial spirit on Nov. 17 at Weill Cornell's Griffis Faculty Club.
- Using Data and AI to Create Better Health Care SystemsJune 26, 2025
Academic medical centers could transform patient care by adopting principles from learning health systems principles, according to researchers from Weill Cornell Medicine and the University of California, San Diego.
- Innovators Encourage Scientists and Physicians to Dive into Technology CommercializationJanuary 9, 2025
In its eighth year, the annual Dean's Symposium on Innovation and Entrepreneurship celebrates innovation and Weill Cornell Medicine’s entrepreneurial spirit, while encouraging and motivating the next generation of innovators, inventors and entrepreneurs.
- Dr. Robert Harrington Honored with Two AwardsNovember 15, 2024
The awards recognized Dr. Harrington's career and leadership achievements.
Show 6 more mentions
- Learning from Excellence: FDA Commissioner Kicks off Dean’s Distinguished Lecture SeriesOctober 21, 2024
Dr. Robert M. Califf, U.S. Food and Drug Administration commissioner, and Dr. Robert A. Harrington, the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, sat down for a fireside chat Oct. 15 in Weill Cornell Medicine's Uris Auditorium.
- Building Trust and Fostering Collaborations Key to Startup FormationNovember 29, 2023
The Dean’s Symposium on Innovation and Entrepreneurship, which took place Nov. 7, celebrated innovation and Weill Cornell Medicine’s entrepreneurial spirit.
- Weill Cornell Medicine Receives Sixth Consecutive HEED Award for Diversity and InclusionOctober 12, 2023
For the sixth consecutive year, Weill Cornell Medicine has been awarded the Health Professions Higher Education Excellence in Diversity (HEED) Award by INSIGHT Into Diversity magazine, which recognizes the institution’s exceptional commitment to diversity and inclusion.
- Boosting Research on “Food is Medicine” Key to Chronic Disease CareOctober 11, 2023
An American Heart Association (AHA) Presidential Advisory, co-authored by a committee including the dean of Weill Cornell Medicine, outlines an ambitious plan to increase rigorous research on initiatives aimed at providing food as medicine for chronic conditions.
- Dr. Robert Harrington Named Dean of Weill Cornell MedicineJune 1, 2023
Dr. Harrington, a cardiologist and chair of the Department of Medicine at Stanford University, will begin his new position on Sept. 12.
External relationships
Leadership Roles
American Heart Association · Cytokinetics, Inc. · Marea Therapeutics, Inc.
Ownership
Atropos Health · Azurna Therapeutics INC · Basking Biosciences INC · Bitterroot Bio, Inc. · Cytokinetics, Inc. · Element Science, Inc. · Marea Therapeutics, Inc.
Advisory/Scientific Board Member
Atropos Health · Azurna Therapeutics INC · Basking Biosciences INC · Bitterroot Bio, Inc. · Corsera Health INC · Edwards Lifesciences Corp. · Element Science, Inc. · HeartBeam INC
Professional Services
Colorado Prevention Center dba CPC Clinical Research · Merck & Co., Inc. · Novartis Pharmaceuticals Corporation
Other Interest
Novartis Pharmaceuticals Corporation
Other
Medscape, LLC